|
T0251 |
Gemcitabine
|
NSC 613327,LY188011 |
Apoptosis
,
Nucleoside Antimetabolite/Analog
,
DNA/RNA Synthesis
,
Autophagy
|
|
Gemcitabine (LY188011) is a synthetic cytosine nucleoside derivative and an inhibitor of DNA synthesis. Gemcitabine has antitumor and antimetabolic activities. Gemcitabine induces autophagy and apoptosis. |
|
T21329 |
Gemcitabine monophosphate disodium salt
|
Gemcitabine monophosphate disodium salt monohydrate,Gemcitabine monophosphate disodium,GemMP |
|
|
R306465 is a novel HDAC inhibitor with broad-spectrum antitumor activity against solid (IC50: 30 to 300 nM) and hematological malignancies. R306465 was found to be a potent inhibitor of HDAC1 and -8 (class I) in vitro. |
|
T6069 |
Gemcitabine hydrochloride
|
Gemcitabine HCl,Gemzar,LY188011,LY 188011 hydrochloride |
Apoptosis
,
Nucleoside Antimetabolite/Analog
,
DNA/RNA Synthesis
,
Autophagy
|
|
Gemcitabine hydrochloride (LY 188011 hydrochloride) is a synthetic cytosine nucleoside derivative and an inhibitor of DNA synthesis. Gemcitabine has antitumor and antimetabolic activities. Gemcitabine induces autophagy a... |
|
T15378 |
Gemcitabine elaidate
|
Gemcitabine 5'-elaidate,Gemcitabine (elaidate),CO-101,CP-4126 |
Apoptosis
,
Nucleoside Antimetabolite/Analog
,
Autophagy
|
|
Gemcitabine elaidate (CP-4126), is a lipophilic, unsaturated fatty acid ester derivative of gemcitabine (dFdC), an antimetabolite deoxynucleoside analogue, with potential antineoplastic activity. Upon hydrolysis intracel... |
